Anti-SeV HN Polyclonal Antibody from ProteoGenix; catalogue ARO-A22448; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-SeV HN Polyclonal Antibody
The Anti-SeV HN Polyclonal Antibody is a highly specific and sensitive antibody that targets the HN protein of the Sendai virus (SeV). This antibody is a valuable tool for studying the biological function of SeV and its role in viral infections.
The HN protein is an important surface glycoprotein of the SeV, which is responsible for viral attachment and entry into host cells. It also plays a crucial role in viral replication and spread. The Anti-SeV HN Polyclonal Antibody binds specifically to the HN protein, inhibiting its function and preventing viral infection.
This antibody is primarily used in research studies to investigate the molecular mechanisms of SeV infection and its pathogenesis. It can also be used in diagnostic assays to detect the presence of SeV in clinical samples. Additionally, the Anti-SeV HN Polyclonal Antibody can be used for the development of antiviral therapies targeting SeV.
– In vitro studies: The Anti-SeV HN Polyclonal Antibody can be used in immunofluorescence and immunoprecipitation assays to analyze the expression and localization of the HN protein in infected cells.
– In vivo studies: This antibody can be used in animal models to study the role of SeV in viral diseases and test the efficacy of potential antiviral treatments.
– Diagnostic assays: The Anti-SeV HN Polyclonal Antibody can be used in ELISA or Western blot assays to detect the presence of SeV in patient samples.
Overall, the Anti-SeV HN Polyclonal Antibody is a highly specific and reliable tool for investigating the biology of SeV and its potential as a therapeutic target. Its use in various experimental settings makes it a valuable asset for researchers and clinicians alike.
Keywords: Anti-SeV HN Polyclonal Antibody, Sendai virus, HN protein, viral infections, research studies, molecular mechanisms, pathogenesis, diagnostic assays, antiviral therapies, immunofluorescence, immunoprecipitation, animal models, ELISA, Western blot, therapeutic target.
ProteoGenix catalogue number ARO-A22448. For research use only.
Target: Hemagglutinin-neuraminidase, HN protein, 3.2.1.18, HN; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Hemagglutinin-neuraminidase, HN protein, 3.2.1.18, HN |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
